Fundraising Fox
Campfieldtx
2 known investors
Find your way into Campfieldtx
Sign up to find every way you can get introduced to Campfieldtx
- Your email: who you already know at Campfieldtx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Campfieldtx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease). The company is advancing the drug into global Phase 2 clinical development.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Campfieldtx do?
- cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease). The company is advancing the drug into global Phase 2 clinical development.
- Who are Campfieldtx's investors?
- Campfieldtx's investors include Frazier Life Sciences, Longitude Capital.